Metraipolis › archive › dc_487935eef4a6

Phase 2, open-label INSPIRE trial to assess the tolerability and effectiveness of transdermal cannabidiol gel in children and adolescents with 22q11.2… — Europe PMC PMID:41888667

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41888667
DOI
10.1186/s11689-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-03T20:41:50.193Z
SHA-256 of the archived text
7fc18bf7d6c8008e80651bc16549afa8a815941c9a5934b54c42aaf681a3fecc
Stable URL of this page
https://metraipolis.com/documento/dc_487935eef4a6

How to cite

Phase 2, open-label INSPIRE trial to assess the tolerability and effectiveness of transdermal cannabidiol gel in children and adolescents with 22q11.2… — Europe PMC PMID:41888667 — Europe PMC (en), https://europepmc.org/article/MED/41888667 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_487935eef4a6 (Metraipolis archive dc_487935eef4a6, sha256 7fc18bf7d6c8008e80651bc16549afa8a815941c9a5934b54c42aaf681a3fecc)
BibTeX
@misc{dc487935eef4a6,
  title = {Phase 2, open-label INSPIRE trial to assess the tolerability and effectiveness of transdermal cannabidiol gel in children and adolescents with 22q11.2… — Europe PMC PMID:41888667},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41888667},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_487935eef4a6; sha256 7fc18bf7d6c8008e80651bc16549afa8a815941c9a5934b54c42aaf681a3fecc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41888667. Agents can read the archived copy with the MCP tool read_document.